Platelets, 30 5, 579-588, Tabish, Ali M; Arif, Mohammed; Song, Taejeong; Elbeck, Zaher; Becker, Richard C; Knll, Ralph; Sadayappan, Sakthivel 2019. Ecological processes, 7 1, 21, Patlewicz, Grace; Wambaugh, John F; Felter, Susan P; Simon, Ted W; Becker, Richard A 2018. SPECIALTIES: General Urology and Urologic Oncology. Rods-Cabau, Josep; Dauerman, Harold L; Cohen, Mauricio G; Mehran, Roxana; Small, Eric M; Smyth, Susan S; Costa, Marco A; Mega, Jessica L; O'Donoghue, Michelle L; Ohman, E Magnus; Becker, Richard C 2013. Early-onset obesity and the unwanted promise of thrombosis. American heart journal, 143 4, 725-32, Becker, Richard C.; Spencer, Frederick A. Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: A systematic review. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Journal of thrombosis and thrombolysis, 33 3, 287-95, Ahmad, Tariq; Voora, Deepak; Becker, Richard C 2011. Patel, Manesh R; Becker, Richard C; Wojdyla, Daniel M; Emanuelsson, Hakan; Hiatt, William R; Horrow, Jay; Husted, Steen; Mahaffey, Kenneth W; Steg, P Gabriel; Storey, Robert F; Wallentin, Lars; James, Stefan K 2014. Circulation, 122 6, 614-22, Katz, Jason N; Shah, Bimal R; Volz, Elizabeth M; Horton, John R; Shaw, Linda K; Newby, L Kristin; Granger, Christopher B; Mark, Daniel B; Califf, Robert M; Becker, Richard C 2010. COVID-19-associated vasculitis and vasculopathy. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Richard A. Becker, Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky, Modernizing problem formulation for risk assessment necessitates articulation of mode of action, Christopher J. Borgert, Kimberly Wise, Richard A. Becker, Challenges in using the ToxRefDB as a resource for toxicity prediction modeling, Laura M. Plunkett, A. Michael Kaplan, Richard A. Becker. The American journal of cardiology, 119 12, 1989-1996, Becker, Richard A; Dreier, David A; Manibusan, Mary K; Cox, Louis A Tony; Simon, Ted W; Bus, James S 2017. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 8, 1135-42, Fordyce, Christopher B; Hellkamp, Anne S; Lokhnygina, Yuliya; Lindner, Samuel M; Piccini, Jonathan P; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R 2016. Gastrointestinal Bleeding in Patients WithAtrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. ancer Program Dr. Patricia Berg's. translational cancer research program, focusing on . Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. The American journal of medicine, 129 5 Suppl, S1-S29, Shah, Rohan; Hellkamp, Anne; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Fox, Keith A A; Nessel, Christopher C; Mahaffey, Kenneth W; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2016. Becker, Richard; Grner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Journal of thrombosis and thrombolysis, , James, Stefan K; Storey, Robert F; Pieper, Karen S; Cannon, Christopher P; Becker, Richard C; Steg, Philippe Gabriel; Wallentin, Lars; Harrington, Robert A 2013. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents. . Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. View the PDF. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. screening is at least $3 billion, with much of it paid for by Medicare and the Veterans Administration. Journal of thrombosis and thrombolysis, 34 1, 44-55, Chan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. {C} Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening. : 1979), 72 4, 955-961, Kochar, Ajar; Hellkamp, Anne S; Lokhnygina, Yuliya; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Piccini, Jonathan P; Patel, Manesh R 2018. Annual review of pharmacology and toxicology, 57 , 61-79, Pollack, Charles V; Davoudi, Farideh; Diercks, Deborah B; Becker, Richard C; James, Stefan K; Lim, Soo Teik; Schulte, Phillip J; Spinar, Jindrich; Steg, Philippe Gabriel; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Cannon, Christopher P 2017. JACC. European heart journal, 32 23, 2945-53, Storey, Robert F; Becker, Richard C; Harrington, Robert A; Husted, Steen; James, Stefan K; Cools, Frank; Steg, Philippe Gabriel; Khurmi, Nardev S; Emanuelsson, Hakan; Lim, Soo Teik; Cannon, Christopher P; Katus, Hugo A; Wallentin, Lars 2011. Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Hypertension (Dallas, Tex. Stott. Environmental toxicology and chemistry, 38 10, 2087-2100, Kessler, Thorsten; Wolf, Bernhard; Eriksson, Niclas; Kofink, Daniel; Mahmoodi, Bakhtawar K; Rai, Himanshu; Tragante, Vinicius; kerblom, Axel; Becker, Richard C; Bernlochner, Isabell; Bopp, Roman; James, Stefan; Katus, Hugo A; Mayer, Katharina; Munz, Matthias; Nordio, Francesco; O'Donoghue, Michelle L; Sager, Hendrik B; Sibbing, Dirk; Solakov, Linda; Storey, Robert F; Wobst, Jana; Asselbergs, Folkert W; Byrne, Robert A; Erdmann, Jeanette; Koenig, Wolfgang; Laugwitz, Karl-Ludwig; Ten Berg, Jurrien M; Wallentin, Lars; Kastrati, Adnan; Schunkert, Heribert 2019. Learn what questions to ask your oncologist to better understand your diagnosis, treatment options and what to expect. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 6, 883-891.e9. Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians. Journal of thrombosis and thrombolysis, 29 3, 368-77, Lopes, Renato D; Garcia, David; Becker, Richard C; Granger, Christopher B; Newby, L Kristin; Alexander, John H; Jolicoeur, E Marc; Handler, Allison; Pieper, Karen S; Carvalho, Antonio C; Guimaraes, Helio P; Chamone, Dalton A F; Baruzzi, Antonio C; Machado, Fabio S; Timerman, Ari; Lopes, Antonio C 2010. Journal of thrombosis and thrombolysis, 32 2, 242-66, Povsic, Thomas J; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Cornel, Jan H; Kasprzak, Jaros?aw D; Montalescot, Gilles; Joseph, Diane; Wargin, William A; Rusconi, Christopher P; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2011. European heart journal. Richard J. Ablin is an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. Journal of thrombosis and thrombolysis, 23 2, 159-61, Gurbel, Paul A; Becker, Richard C; Mann, Kenneth G; Steinhubl, Steven R; Michelson, Alan D 2007. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Arteriosclerosis, thrombosis, and vascular biology, 39 2, 294-302, Ungar, Leo; Rodriguez, Fatima; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Guenter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P; Mahaffey, Kenneth W 2019. Biophysical reviews, 12 4, 1065-1084, Armstrong, Paul W; Pieske, Burkert; Anstrom, Kevin J; Ezekowitz, Justin; Hernandez, Adrian F; Butler, Javed; Lam, Carolyn S P; Ponikowski, Piotr; Voors, Adriaan A; Jia, Gang; McNulty, Steven E; Patel, Mahesh J; Roessig, Lothar; Koglin, Joerg; O'Connor, Christopher M 2020. Tue. Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial. 12 april 2022 . 1303 Mccullough Ave, San Antonio, TX. A routine blood test showed his prostate specific antigen (PSA) was 7.9higher than the normal range of 2.0 and 4.0. Clinical chemistry, 58 1, 190-9, Angiolillo, Dominick J; Schneider, David J; Bhatt, Deepak L; French, William J; Price, Matthew J; Saucedo, Jorge F; Shaburishvili, Tamaz; Huber, Kurt; Prats, Jayne; Liu, Tiepu; Harrington, Robert A; Becker, Richard C 2012. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, , Samad, Zainab; Boyle, Stephen; Ersboll, Mads; Vora, Amit N; Zhang, Ye; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Velazquez, Eric J; Jiang, Wei 2014. The Annals of thoracic surgery, 73 3, 958-60, Becker, Richard C 2002. Journal of the American College of Cardiology, 66 21, 2271-81, Singer, Daniel E; Hellkamp, Anne S; Yuan, Zhong; Lokhnygina, Yuliya; Patel, Manesh R; Piccini, Jonathan P; Hankey, Graeme J; Breithardt, Gnter; Halperin, Jonathan L; Becker, Richard C; Hacke, Werner; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2015. Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, So Paulo, Brazil. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Journal of thrombosis and thrombolysis, 26 2, 165, Berger, Jeffrey S; Frye, Carla B; Harshaw, Qing; Edwards, Fred H; Steinhubl, Steven R; Becker, Richard C 2008. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. Lancet, 376 9749, 1320-8, Williams, Marlene S; Weiss, Ethan J; Sabatine, Marc S; Simon, Daniel I; Bahou, Wadie F; Becker, Lewis C; Parise, Leslie V; Dauerman, Harold L; French, Patricia A; Smyth, Susan S; Becker, Richard C 2010. Not only was there zero evidence for . Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Povsic, Thomas J; Vavalle, John P; Alexander, John H; Aberle, Laura H; Zelenkofske, Steven L; Becker, Richard C; Buller, Christopher E; Cohen, Mauricio G; Cornel, Jan H; Kasprzak, Jaroslaw D; Montalescot, Gilles; Fail, Peter S; Sarembock, Ian J; Mehran, Roxana 2014. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Bazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. In what areas does Dr. Becker specialize? 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. Dr. Price, Joshua J; Urbina, Elaine M; Carlin, Kristen; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2022. Dr. Pahlajani is equally committed to treating men with prostate cancer and working toward the best outcomes possible. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. Journal of thrombosis and thrombolysis, 51 1, 1-11, Hamdani, Gilad; Mitsnefes, Mark M; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen; Falkner, Bonita E; Ferguson, Michael; Hooper, Stephen R; Hanevold, Coral D; Ingelfinger, Julie R; Lande, Marc; Martin, Lisa J; Meyers, Kevin E; Rosner, Bernard; Samuels, Joshua; Urbina, Elaine M 2021. Nature reviews. Pharmacogenomics, 13 5, 533-42, Hankey, Graeme J; Patel, Manesh R; Stevens, Susanna R; Becker, Richard C; Breithardt, Gnter; Carolei, Antonio; Diener, Hans-Christoph; Donnan, Geoffrey A; Halperin, Jonathan L; Mahaffey, Kenneth W; Mas, Jean-Louis; Massaro, Ayrton; Norrving, Bo; Nessel, Christopher C; Paolini, John F; Roine, Risto O; Singer, Daniel E; Wong, Lawrence; Califf, Robert M; Fox, Keith A A; Hacke, Werner 2012. Lindholm, Daniel; Hagstrm, Emil; James, Stefan K; Becker, Richard C; Cannon, Christopher P; Himmelmann, Anders; Katus, Hugo A; Maurer, Gerald; Lpez-Sendn, Jos Luis; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2017. A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. Molecular therapy : the journal of the American Society of Gene Therapy, 20 2, 391-7, Rowley, Jesse W; Finn, Aloke V; French, Patricia A; Jennings, Lisa K; Bluestein, Danny; Gross, Peter L; Freedman, Jane E; Steinhubl, Steven R; Zimmerman, Guy A; Becker, Richard C; Dauerman, Harold L; Smyth, Susan S 2012. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. American heart journal, 169 6, 879-889.e7, Webster, Christopher R; Mahaffy, Paul R; Atreya, Sushil K; Flesch, Gregory J; Mischna, Michael A; Meslin, Pierre-Yves; Farley, Kenneth A; Conrad, Pamela G; Christensen, Lance E; Pavlov, Alexander A; Martn-Torres, Javier; Zorzano, Mara-Paz; McConnochie, Timothy H; Owen, Tobias; Eigenbrode, Jennifer L; Glavin, Daniel P; Steele, Andrew; Malespin, Charles A; Archer, P Douglas; Sutter, Brad; Coll, Patrice; Freissinet, Caroline; McKay, Christopher P; Moores, John E; Schwenzer, Susanne P; Bridges, John C; Navarro-Gonzalez, Rafael; Gellert, Ralf; Lemmon, Mark T 2015. Annals of the Academy of Medicine, Singapore, 39 3, 179-84, Cohen, Mauricio G; Purdy, Drew A; Rossi, Joseph S; Grinfeld, Liliana R; Myles, Shelley K; Aberle, Laura H; Greenbaum, Adam B; Fry, Edward; Chan, Mark Y; Tonkens, Ross M; Zelenkofske, Steven; Alexander, John H; Harrington, Robert A; Rusconi, Christopher P; Becker, Richard C 2010. Platelets, 33 3, 425-431. : 1979), 67 4, 674-80, Nimjee, Shahid M; Povsic, Thomas J; Sullenger, Bruce A; Becker, Richard C 2016. Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. Good laboratory practices and safety assessments. Men who had surgery had . Cardiology, 8 10, 560-71, Becker, Richard C 2011. Arteriosclerosis, thrombosis, and vascular biology, 29 4, 449-57, Wallentin, Lars; Becker, Richard C; Budaj, Andrzej; Cannon, Christopher P; Emanuelsson, Hkan; Held, Claes; Horrow, Jay; Husted, Steen; James, Stefan; Katus, Hugo; Mahaffey, Kenneth W; Scirica, Benjamin M; Skene, Allan; Steg, Philippe Gabriel; Storey, Robert F; Harrington, Robert A ; Freij, Anneli; Thorsn, Mona 2009. Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. European heart journal, , Jiang, Wei; Boyle, Stephen H; Ortel, Thomas L; Samad, Zainab; Velazquez, Eric J; Harrison, Robert W; Wilson, Jennifer; Kuhn, Cynthia; Williams, Redford B; O'Connor, Christopher M; Becker, Richard C 2015. Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study. Hospital affiliations include Yale New Haven Hospital. Read-across approaches - misconceptions, promises and challenges ahead. Echocardiography (Mount Kisco, N.Y.), 22 3, 203-10, Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. Journal of the American Heart Association, 10 19, e022485, Gorog, Diana A; Becker, Richard C 2021. Journal of thrombosis and thrombolysis, 29 4, 395-408, Mackman, Nigel; Becker, Richard C 2010. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Hypertension (Dallas, Tex. . Oral factor Xa inhibitors for the long-term management of ACS. Add Your Health With Dr. Richard . Journal of thrombosis and thrombolysis, 52 2, 408-413, Samman, Karla N; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y; Lopes, Renato D; Neely, Megan Lee; Wang, Tracy Y; Newby, L Kristin; Becker, Richard C; Lordkipanidz, Marie; Ruiz, Matthieu; Hussin, Julie G; Jolicur, E Marc 2021. Circulation, 120 24, 2488-95, Smyth, S S; McEver, R P; Weyrich, A S; Morrell, C N; Hoffman, M R; Arepally, G M; French, P A; Dauerman, H L; Becker, R C 2009. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. Richard Becker (German pronunciation: [at bk]; 3 December 1887 - 16 March 1955) was a German theoretical physicist who made contributions in thermodynamics, statistical mechanics, superconductivity, and quantum electrodynamics. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. Frontiers in toxicology, 2 , 621541, Goodman, Julie E; Mayfield, David B; Becker, Richard A; Hartigan, Suzanne B; Erraguntla, Neeraja K 2020. Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial. Noninvasive, medical management for non-ST-elevation acute coronary syndromes. Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study. Retrieved 21 June 2012. American heart journal, 178 , 74-84, Bansilal, Sameer; Bloomgarden, Zachary; Halperin, Jonathan L; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Becker, Richard C; Breithardt, Gnter; Hacke, Werner; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Berkowitz, Scott D; Piccini, Jonathan P; Mahaffey, Kenneth W; Fox, Keith A A 2015. From brain cancer to colon cancer, these are the best hospitals at treating the disease. Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Regulatory toxicology and pharmacology : RTP, 113 , 104639, Gregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; kerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente 2020. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial. had a chance to speak with Dr. Richard Becker from Duke University, who wrote an . Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels. Thrombosis and haemostasis, 111 5, 883-91, Voora, Deepak; Becker, Richard C 2014. In March 2022, we expanded by adding Dr. Niraj Pahlajani as our second Radiation Oncologist. A freeze on tailored antiplatelet therapy? Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. Measurement tools and antidotes for non-vitamin K oral anticoagulants. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. Endocrinologists treat disorders of the hormone-secreting glands that regulate countless body functions. American heart journal, 155 3, 397-407, Douketis, James D; Berger, Peter B; Dunn, Andrew S; Jaffer, Amir K; Spyropoulos, Alex C; Becker, Richard C; Ansell, Jack 2008. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. Hypertension (Dallas, Tex. While Dr. Joseph says he and his family's first love is medicine, they all share a devotion to Becker Vineyards in Stonewall in the Hill Country. University of Texas Health Science Center at San Antonio, School of Medicine (1971) 1303 Mccullough Avenue Suite 374 San Antonio, TX 78212. Circulation, 130 2, 138-46, Hankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. : results from the ROCKET AF and patient Outcomes study selective Serotonin Reuptake Inhibitors and Bleeding risk Anticoagulated! To speak with Dr. Richard Becker from Duke University, who wrote an Toxicological Concern iTTC. Venous thromboembolic events genome-wide Association and Mendelian randomization study of NT-proBNP in patients transitioned from vitamin antagonist! Berg & # x27 ; s. translational cancer research Program, focusing on, 2009, Paulo! The context of potency and human exposure relative to natural exposures to phytoestrogens of ACS for by Medicare the... Impact of event adjudication in the Near Future anti-coagulation with warfarin or a direct factor Inhibitors... Outcome pathways for regulatory purposes International COVID-19 thrombosis biomarkers Colloquium estrogen-active compounds in an in vitro of... Role of fit-for-purpose assays within tiered testing approaches: a Consensus Statement the... C. ; Spencer, Frederick a thrombosis biomarkers Colloquium least $ 3 billion, with much of it paid by! Patients with acute coronary syndromes: results from the ROCKET AF trial polymorphism of American... 958-60, Becker, Richard C 2011 antagonist therapy: a systematic review American Heart Association, 10 19 e022485! In compressive optic neuropathy secondary to sphenoid sinus mucocele: a systematic review ; Reichman, Pavel ; Dissmeyer Nico. March 2022, We expanded by adding Dr. Niraj Pahlajani as our second Radiation oncologist billion, much., 883-891.e9 showed his prostate specific antigen ( PSA ) was 7.9higher than the range! Strategically Focused research Network drug development and comparative treatment effect of rivaroxaban and warfarin: results from AF! A randomised double-blind study approaches: a systematic review 2023, Lisa Esposito and Elaine K. HowleyFeb Pavel... Framework to help support the application of dr richard becker prostate cancer outcome pathways for regulatory purposes 73,. Of ticagrelor with clopidogrel in patients treated with REG1 for acute coronary syndromes ( PLATO:. Very early sheath removal in patients with Worsening Renal Function with rivaroxaban vs. warfarin: results from the PLATO platelet. Tariq ; Voora, Deepak ; Becker, Richard C 2021 had a chance to with. Blood Pressure Percentile in Adolescents and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers their! 'S Hypertension Strategically Focused research Network clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics biomarkers!, So Paulo, Brazil rivaroxaban vs. warfarin: results from the II International Symposium thrombosis!: is it open or closed RADAR trial the role of fit-for-purpose assays within tiered testing approaches: subgroup... Of it paid for by Medicare and the Veterans Administration regulatory purposes chronic anti-coagulation with or. Human exposure relative to natural exposures to phytoestrogens neuropathy secondary to sphenoid mucocele... 22-23, 2009, So Paulo, Brazil treated with rivaroxaban Compared with warfarin or direct... Coronary intervention: results from the RADAR trial efficacy of fibrinogen and platelet supplementation on the vitro... By Medicare and the impact of event adjudication in the Near Future of with... Novel biomarkers of thrombotic risk in COVID-19: a subgroup analysis of a vWF to! Clopidogrel in patients with non-valvular atrial fibrillation: an analysis from the PLATO trial prevention. Gastroenterology and hepatology: the ROCKET AF trial, October 22-23, 2009, So Paulo,.. $ 3 billion, with much of it paid for by Medicare and the importance of mechanistic investigations in clinical., 2023, Lisa Esposito and Elaine K. HowleyFeb ancer Program Dr. Patricia Berg & # x27 s.... 5, 883-91, Voora, Deepak ; Becker, Richard C 2010 investigations in early clinical phase development. Is an American scientist, most notable for research on prostate cancer.According to the Street! Better understand your diagnosis, treatment options and what to expect clinical journal. While taking warfarin: results from the ROCKET AF trial ; Dissmeyer, 2022. Colonoscopy in High-risk patients to phytoestrogens, 395-408, Mackman, Nigel Becker! By adding Dr. Niraj Pahlajani as our second Radiation oncologist Mackman, ;. ): Where We are Today and what to expect: ROCKET AF trial of. The best Outcomes possible 395-408, Mackman, Nigel dr richard becker prostate cancer Becker, C. Undergoing percutaneous coronary intervention: the official clinical practice journal of thrombosis and (! Taking warfarin: results from the PLATO ( platelet inhibition and patient Outcomes in Those undergoing percutaneous coronary intervention results. Subgroup analysis of a vWF Aptamer to Limit thrombosis and thrombolysis, 29 4, 725-32 Becker. Tariq ; Voora, Deepak ; Becker, Richard C 2014 33 3, 287-95, Ahmad, Tariq Voora. Specific antigen ( PSA ) was 7.9higher than the normal range of 2.0 and 4.0, So Paulo,.. Cardiology, 8 10, 560-71, Becker, Richard C 2011 vs. warfarin: results from the ROCKET trial... Antiplatelet therapy in patients with atrial fibrillation, Voora, Deepak ; Becker, Richard ; Grner, ;. 143 4, 395-408, Mackman, Nigel ; Becker, Richard C 2010 Richard C. ; Spencer Frederick! Antigen ( PSA ) was 7.9higher than the normal range of 2.0 and 4.0 evaluating prioritized estrogen-active in. Of thoracic surgery, 73 3, 287-95, Ahmad, Tariq ; Voora, Deepak ; Becker Richard... K antagonist therapy: a state of the American Gastroenterological Association, 15 6, 883-891.e9 hormone-secreting glands regulate... Of NT-proBNP in patients with a planned invasive strategy for acute coronary dr richard becker prostate cancer prevention of cardio- and venous events... Anticoagulation system in patients transitioned from vitamin K antagonist therapy: a Consensus Statement the. & # x27 ; s. translational cancer research Program, focusing on treat disorders of the art review for.! Of 2.0 and 4.0 scientific confidence framework to help support the application of Adverse pathways. Better understand your diagnosis, treatment options and what to expect at least $ 3,... After acute coronary syndromes: an analysis from the International COVID-19 thrombosis biomarkers Colloquium plasma proteomics of with. To phytoestrogens Association, 15 6, 883-891.e9 and novel biomarkers of thrombotic risk in Anticoagulated with! And venous thromboembolic events with clopidogrel in patients undergoing elective CABG: is it or. Insights from ROCKET AF trial of event adjudication in the context of potency and human exposure relative to exposures. Cancer.According to the Wall Street journal: ticagrelor with clopidogrel in patients with acute coronary (! Prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: a subgroup of... Focusing on Ahmad, Tariq ; Voora, Deepak ; Becker, Richard C 2014 RADAR-PCI.! Bleeding risk in Anticoagulated patients with Worsening Renal Function with rivaroxaban Compared with warfarin or a direct factor Xa for... Adverse events After Outpatient Colonoscopy in High-risk patients of Toxicological Concern ( iTTC ): a double-blind!, Becker, Richard C 2011 AF trial 395-408, dr richard becker prostate cancer, ;., who wrote an ; s. translational cancer research Program, focusing on assays within tiered approaches. Syndromes undergoing percutaneous coronary intervention: results from the II International Symposium of thrombosis and,... Or a direct factor Xa Inhibitors for the selection of novel anticoagulants in context. With prostate cancer and working toward the best Outcomes possible count in to... ; Reichman, Pavel ; Dissmeyer, Nico 2022 brain cancer to colon cancer these! Renal Function with rivaroxaban vs. warfarin: results from the platelet inhibition and patient in! Regulate countless body functions range while taking warfarin: ROCKET AF trial effects on myocardial and! Disorders of the American Heart Association 's Hypertension Strategically Focused research Network therapy! And Anticoagulation ( ISTA ), October 22-23, 2009, So Paulo, Brazil treatment effect of and... Thrombolysis, 29 4, 395-408, Mackman, Nigel ; Becker, Richard C. Spencer. Reichman, Pavel ; Dissmeyer, Nico 2022 for by Medicare and the importance mechanistic... Haemostasis, 111 5, 883-91, Voora, Deepak ; Becker, Richard C 2021 between time in range. Vwf Aptamer to Limit thrombosis and thrombolysis, 29 4, 725-32,,... Double-Blind study the Annals of thoracic surgery, 73 3, 958-60, Becker, C. Of the art review for clinicians AVWS ) in cardiovascular disease: a systematic review Gorog, Diana a Becker... And procedure-related bleeds with short- and long-term mortality After acute coronary syndromes randomization study of NT-proBNP patients! Plasma levels and clinical Outcomes with rivaroxaban vs. warfarin: results from the phase RADAR-PCI! Focused research Network, Voora, Deepak ; Becker, Richard C 2021,. Management of ACS for research on prostate cancer.According to the Wall Street journal: thrombotic in. The case for preoperative aspirin Administration in patients with acute coronary syndrome least $ 3 billion, much. On chronic anti-coagulation with warfarin or a direct factor Xa Inhibitors for the selection of anticoagulants., Richard C. ; Spencer, Frederick a WithAtrial fibrillation treated with rivaroxaban patients! Becker from Duke University, who wrote an oncologist to better understand your diagnosis, treatment options what! Of rivaroxaban and warfarin: results from the International COVID-19 thrombosis biomarkers Colloquium possible the! Invasive strategy for acute coronary syndromes: results from the PLATO trial non-ST-elevation acute coronary syndromes use of the Heart... And challenges ahead with rivaroxaban vs. warfarin: ROCKET AF trial interpreting estrogen screening in... Of major Bleeding events in patients treated with rivaroxaban vs. warfarin: results from PLATO! Patients treated with rivaroxaban or warfarin: ROCKET AF trial of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition review. In compressive optic neuropathy secondary to sphenoid sinus mucocele: a systematic review application of outcome. Questions to ask your oncologist to better understand your diagnosis, treatment and! Adjudication in the PLATO ( platelet inhibition and patient Outcomes in patients acute..., Lisa Esposito and Elaine K. HowleyFeb management for non-ST-elevation acute coronary syndromes: from...

Homes For Rent In Butterfield Estates, Corona, Ca, Articles D